rss
Br J Ophthalmol 2007;91:379-384 doi:10.1136/bjo.2006.100628
  • Laboratory science - Extended reports

Selective blockade of phosphodiesterase types 2, 5 and 9 results in cyclic 3′5′ guanosine monophosphate accumulation in retinal pigment epithelium cells

  1. R M H Diederen1,
  2. E C La Heij2,
  3. M Markerink-van Ittersum1,
  4. A Kijlstra2,
  5. F Hendrikse2,
  6. J de Vente1
  1. 1Department of Psychiatry and Neuropsychology, European Graduate School of Neuroscience, University of Maastricht, Maastricht, The Netherlands
  2. 2Department of Ophthalmology, Eye Research Institute Maastricht, University Hospital Maastricht, Maastricht, The Netherlands
  1. Correspondence to: R Diederen Department of Ophthalmology, University Hospital Maastricht, PO Box 5800, P Debyelaan 25, 6202 AZ Maastricht, The Netherlands; r.diederen{at}NP.unimaas.nl
  • Accepted 6 August 2006
  • Published Online First 30 August 2006

Abstract

Aim: To investigate which phosphodiesterase (PDE) is involved in regulating cyclic 3′5′ guanosine monophosphate breakdown in retinal pigment epithelium (RPE) cells.

Methods: cGMP content in the cultured RPE cells (D407 cell line) was evaluated by immunocytochemistry in the presence of non-selective or isoform-selective PDE inhibitors in combination with the particulate guanylyl cyclase stimulator atrial natriuretic peptide (ANP) or the soluble guanylyl cyclase stimulator sodium nitroprusside (SNP). mRNA expression of PDE2, PDE5 and PDE9 was studied in cultured human RPE cells and rat RPE cell layers using non-radioactive in situ hybridisation.

Results: In the absence of PDE inhibitors, cGMP levels in cultured RPE cells are very low. cGMP accumulation was readily detected in cultured human RPE cells after incubation with Bay60–7550 as a selective PDE2 inhibitor, sildenafil as a selective PDE5 inhibitor or Sch51866 as a selective PDE9 inhibitor. In the presence of PDE inhibition, cGMP content increased markedly after stimulation of the particulate guanylyl cyclase. mRNA of PDE2,PDE5 and PDE9 was detected in all cultured human RPE cells and also in rat RPE cell layers.

Conclusions: PDE2, PDE5 and PDE9 have a role in cGMP metabolism in RPE cells.

Footnotes

  • Published Online First 30 August 2006

  • Funding: This study was supported by the Algemene Nederlandse Vereniging ter Voorkoming van Blindheid.

  • Competing interests: None.

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All versions of this article:
    1. bjo.2006.100628v1
    2. 91/3/379 most recent

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.